RTN4 and myeloid sarcoma: Interestingly, the expression of a soluble Nogo-A fragment was found exclusively in patients with MS (in over 90% of CSF samples from patients with MS) in comparison to meningo-encephalomyelitis, other neurological diseases, and autoimmune disorders [68].